Gabapentinoids are prescribed to tens of millions of Americans every year for neuropathic pain, fibromyalgia, and seizures, and their side effects are often the biggest reason patients stop treatment. The comparison of gabapentin vs pregabalin side effects is important because the drugs work on the same calcium channel but differ in potency, pharmacokinetics, and tolerability. Our medical conditions guide covers nerve pain in more depth. Short answer: pregabalin tends to have more predictable absorption and may cause more weight gain and edema, while gabapentin often causes more dose-related dizziness and sedation at higher doses.
Quick Comparison Overview
Gabapentin (Neurontin) and pregabalin (Lyrica) both bind to the alpha-2-delta subunit of voltage-gated calcium channels, reducing neurotransmitter release in overactive nerve pathways. Pregabalin is the newer, more potent cousin; milligram for milligram, it produces a stronger effect, which is why its doses are lower.
According to MedlinePlus, both drugs are FDA-approved for different subsets of neuropathic pain, and both appear on the DEA Schedule V controlled substances list because of misuse potential.
Most Common Side Effects
Both drugs share a core set of side effects: dizziness, drowsiness, fatigue, peripheral edema, weight gain, blurred vision, dry mouth, unsteadiness, and difficulty concentrating. These effects are most pronounced in the first 2 to 4 weeks and often fade as the body adapts.
Pregabalin’s side effects tend to appear more predictably because its absorption is linear and dose-proportional. Gabapentin’s absorption saturates at higher doses, meaning patients sometimes experience big swings in side effects when doses are pushed past 1,800 to 2,400 mg per day.
Dizziness and Sedation
In clinical trials, dizziness affects roughly 20 to 30% of patients on either drug, and sedation affects 15 to 25%. A Cochrane Review of gabapentin for neuropathic pain found that dizziness was one of the leading reasons for discontinuation. Similar numbers appear in pregabalin trials.
Both drugs amplify the sedating effects of alcohol, opioids, benzodiazepines, and sleep aids. The FDA issued a 2019 safety warning about serious breathing problems when gabapentinoids are combined with opioids or used in elderly patients with respiratory conditions.
Weight Gain and Edema
Weight gain is a frequently cited complaint with both drugs, but it appears more prominent with pregabalin in some trials. Gains of 5 to 10 pounds over several months are not unusual, and fluid retention contributes to the total. Pregabalin is more commonly associated with peripheral edema, sometimes enough to require dose reduction or discontinuation.
Gabapentin can also cause weight gain, especially at higher doses, but it is often attributed to increased appetite and reduced activity from sedation rather than direct fluid retention.
Cognitive Effects
Both drugs can cause cognitive slowing, word-finding difficulty, and impaired concentration. These effects are usually mild at therapeutic doses but can be significant in elderly patients or those on higher doses. Pregabalin’s more predictable pharmacokinetics can make cognitive side effects more consistent, while gabapentin’s variable absorption sometimes produces unpredictable fog.
Mood changes are also reported. Depression, anxiety, and rarely suicidal ideation are listed side effects for both, and patients and caregivers should watch for new mood symptoms during the first few months of treatment.
Dependence and Withdrawal
Both drugs can cause physical dependence after prolonged use. Abrupt discontinuation can trigger withdrawal symptoms including insomnia, anxiety, sweating, nausea, and in rare cases seizures. Tapering over at least a week (longer for chronic use) is standard practice.
Misuse potential exists, particularly in patients with opioid use disorder, where gabapentinoids can enhance opioid effects. Both drugs are Schedule V in several states (and federally for pregabalin), reflecting a recognized but modest abuse risk.
Emergency callout: Call Poison Control at 1-800-222-1222 for suspected overdose of either drug. Seek emergency care for difficulty breathing, severe drowsiness leading to unresponsiveness, new seizures, or suicidal thoughts.
Dosing and Tolerability
Gabapentin is typically started at 300 mg at bedtime and titrated to 900 to 3,600 mg per day divided into three doses. Pregabalin starts at 75 mg twice daily and is adjusted up to 150 to 600 mg per day in two or three divided doses. Slower titration reduces dizziness and sedation meaningfully.
Kidney function matters for both drugs because both are renally cleared. Elderly patients and those with chronic kidney disease require dose reduction to avoid excessive side effects.
Cost and Availability
Generic gabapentin is inexpensive — often under $10 per month with a GoodRx coupon. Generic pregabalin is available and has dropped considerably since losing exclusivity, now typically $20 to $40 per month with discount cards, though brand Lyrica is much more expensive. For patients trying to decide between the two on cost grounds, gabapentin is the clear winner.
Drug Interactions and Warnings
Both drugs interact primarily through additive CNS depression with alcohol, opioids, benzodiazepines, antihistamines, and sleep aids. They also potentiate each other if accidentally coprescribed. Antacids containing aluminum or magnesium can reduce gabapentin absorption and should be spaced by 2 hours.
Related reading: see our articles on pregabalin vs gabapentin and Lyrica vs gabapentin for nerve pain.
Frequently Asked Questions
Which drug has fewer side effects overall?
Evidence is mixed. Some patients tolerate gabapentin better because of its cheaper price and simpler tapering, while others prefer pregabalin’s predictable absorption. Individual response is the deciding factor.
Does pregabalin cause more weight gain than gabapentin?
Clinical trials suggest pregabalin has a slightly higher rate of weight gain and edema, though both drugs can contribute. Monitoring weight during the first few months of therapy helps catch significant gains early.
Can I stop these drugs suddenly?
No. Tapering over at least a week is standard to avoid withdrawal symptoms. Chronic users may need several weeks of gradual reduction under medical supervision.
Are gabapentinoids addictive?
They have lower addiction potential than opioids or benzodiazepines, but physical dependence and misuse do occur, especially in people with other substance use disorders. The DEA classifies pregabalin as Schedule V federally.
The Bottom Line
Gabapentin and pregabalin share similar side effect profiles, with dizziness, sedation, weight gain, and edema topping the list. Pregabalin’s effects are more predictable because of linear absorption, and it tends to cause more fluid retention. Gabapentin’s side effects can be more variable but the drug is dramatically cheaper. Tapering slowly, screening for kidney function, avoiding combinations with opioids or alcohol, and monitoring mood and weight will keep most patients out of trouble. Talk to your prescriber if side effects limit your function — switching between the two drugs sometimes produces better tolerability for an individual patient.